Arboreal Bioinnovations raised ₹230 Cr in Series A funding to expand manufacturing and R&D for its clean-label B2B ingredient portfolio, which already supplies over 1,100 brands.
Arboreal Bioinnovations is a Lucknow-based startup that manufactures proprietary functional ingredients, including plant proteins, natural zero-calorie sweeteners, cocoa-based derivatives, and functional fibres, and sells them to food, beverage, and nutraceutical brands rather than directly to consumers. The company closed a ₹230 Cr (approximately $24 Mn) Series A round in mid-2026, co-led by EAAA Alternatives and Omnivore, with continued backing from Rainmatter, the investment arm of Zerodha.
Founded in 2018 by Swati Pandey and Manish Chauhan, Arboreal says it currently supplies more than 1,100 brands and claims its ingredients have powered over 300 product launches in the past 18 months. Its five named flagship ingredients are Pyure, Bioprot, COCOCO, Evo, and Ori. The company has not published detailed technical datasheets or FSSAI approval references for each ingredient in its public communications, so independent verification of specific functional claims remains limited at this stage.
The fresh capital is earmarked for three areas: expanding manufacturing capacity, strengthening R&D, and accelerating commercialisation of ingredients still in development.
What changed
For most of the past decade, the clean-label movement in India played out almost entirely at the finished-product level. D2C brands reformulated snacks, protein bars, and supplements to drop artificial colours, synthetic preservatives, and cheap fillers, then marketed the absence of those ingredients as a selling point. What this round signals is that investor attention is now moving one step upstream, to the companies that actually make the cleaner building blocks those brands need.
Omnivore, one of the lead investors, focuses on agri and food-tech bets with a farm-to-fork orientation. Rainmatter has backed several health and wellness startups. The combination suggests the round is not purely a financial play but a bet that ingredient supply will become a bottleneck as more Indian brands try to reformulate away from synthetic additives.
India's specialty food ingredients market is projected to grow steadily over the coming years, driven by protein enrichment, sugar reduction, and gut-health product categories. Arboreal sits squarely across all three.
The B2B positioning matters here. Unlike D2C nutrition brands such as TruNative, which raised $30 Mn in June 2026 to push finished products into offline retail, or Good Monk, which secured ₹33 Cr to scale plant-based protein mixes, Arboreal does not carry the inventory and marketing risk of consumer-facing products. Its revenue depends on how many brands choose its ingredients over cheaper synthetic or commodity alternatives, which is a different and arguably more durable moat if the science holds up.
The honest caveat: Arboreal's public materials lean heavily on the phrase "science-backed" without linking to peer-reviewed studies or FSSAI novel food approvals for specific ingredients. Buyers should ask for that documentation before assuming a proprietary ingredient is meaningfully different from a commodity equivalent.
What buyers and food-brand founders should do
If you run a food or nutraceutical brand and are sourcing ingredients for a clean-label reformulation, this funding round is worth tracking for a practical reason: Arboreal is now better capitalised to scale supply, which historically means shorter lead times and more consistent batch quality. That said, a funding announcement is not a product audit.
Before listing any Arboreal ingredient on your label, confirm the following with their team directly.
- FSSAI approval status for each ingredient under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations. Novel functional ingredients sometimes sit in a regulatory grey zone until FSSAI issues a specific approval or a "no objection" letter.
- Whether the ingredient is vegan, Jain-compliant, or gluten-free at the manufacturing level, not just by formulation intent. Cross-contamination at shared facilities can invalidate a claim.
- Third-party certificate of analysis (CoA) data for each batch, not just internal QC numbers.
For consumers reading ingredient labels on finished products, the presence of an Arboreal-supplied ingredient (if disclosed at all, which B2B suppliers rarely are by name) does not automatically mean the product is additive-free. What matters is whether the ingredient itself is a whole or minimally processed input versus a highly refined extract with a long processing chain. A "natural zero-calorie sweetener," for instance, could be stevia leaf extract with minimal processing or a highly purified rebaudioside isolate produced through multi-step solvent extraction. Both can carry a clean-label claim; they are not the same thing nutritionally or from a processing standpoint.
Arboreal has not published its processing methodology for Pyure (its sweetener product) in any publicly accessible document as of this writing. That gap is worth flagging to the brand using it, not to Arboreal directly, since the brand carries FSSAI labelling responsibility.
For home cooks and recipe developers, none of Arboreal's ingredients appear to be available in retail formats. The company is a B2B supplier, so the practical impact on home kitchens is indirect: the protein bar, functional drink, or fortified flour you buy at a store may increasingly contain an Arboreal-sourced input as more brands sign on post-funding.
The broader takeaway is that India's clean-label supply chain is maturing. Ingredient innovation used to mean importing specialty inputs from Europe or the US at a premium. A well-funded domestic supplier with manufacturing in Lucknow and a stated R&D pipeline changes that calculus for smaller Indian brands that previously could not afford the minimum order quantities from international ingredient houses.